Notably, the serum HER2 levelsdetected by dot blot assay and tissue HER2 status examined by IHC werepositively correlated in 126 primary breast cancer patients (Spearman'srho = 0.301,P = 0.001; Table 1, Fig. 3A). Here, ERBB2 is linked to breast cancer.